# CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
Canonical URL: https://biopharmsignal.com/news/CRSP/crispr-therapeutics-highlights-strategic-priorities-and-anticipated-2026-milestones
Ticker: CRSP
Company: CRISPR Therapeutics
Source: CRISPR Therapeutics
Published: 2026-01-12 13:36 EST
Original Source URL: https://ir.crisprtx.com
## Summary

 -2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY ®   launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading gene-editing and siRNA platforms across cardiovascular, autoimmune, oncology and rare diseases-

## Article Body
-2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY ®   launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading gene-editing and siRNA platforms across cardiovascular, autoimmune, oncology and rare diseases-
## Recent Company News
- 2026-05-28 12:00 EST — [CRISPR Therapeutics to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-participate-in-upcoming-investor-conferences) — Source: CRISPR Therapeutics
- 2026-05-06 12:30 EST — [CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference) — Source: CRISPR Therapeutics
- 2026-05-04 20:30 EST — [CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results) — Source: CRISPR Therapeutics
- 2026-04-07 12:00 EST — [CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: CRISPR Therapeutics
- 2026-03-11 11:00 EST — [CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-prices-upsized-convertible-senior-notes-offering) — Source: CRISPR Therapeutics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)